Patrizia Cavazzoni | |
|---|---|
 Official FDA Portrait | |
| Director of the Center for Drug Evaluation and Research[1] | |
| Assumed office April 12, 2021 Acting: May 2020 – April 2021 | |
| Preceded by | Janet Woodcock |
| Acting Principal Deputy Commissioner of Food and Drugs[2] | |
| In office January 2019 – February 2019 | |
| Succeeded by | Amy Abernethy |
| Deputy Center Director for Operations of the FDA Center for Drug Evaluation and Research | |
| In office January 2018 – May 2020 | |
| Personal details | |
| Education | McGill University (MD)[2] |
Patrizia Cavazzoni is the director of the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER). Prior to this position she worked at Pfizer and had been a psychiatrist
- ^ "CDER Leadership Bios". U.S. Food and Drug Administration. April 12, 2021.
- ^ a b "Patrizia Cavazzoni M.D." U.S. Food and Drug Administration. April 12, 2021.